---
title: "Somnigroup International Inc. Stock 12‑Month Price Target Cut to $93, Implies 43% Upside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295175034.md"
description: "Somnigroup International Inc.'s average 12-month price target was lowered to $93 from $94.56 by nine analysts, with forecasts ranging between $76 and $105. Based on the August 6 closing price, this implies a 43% upside potential. The consensus rating remains 'Buy' across 12 covering analysts, comprising 10 Buy ratings, 2 Hold ratings, and no Sell ratings."
datetime: "2026-08-07T03:20:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295175034.md)
  - [en](https://longbridge.com/en/news/295175034.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295175034.md)
---

# Somnigroup International Inc. Stock 12‑Month Price Target Cut to $93, Implies 43% Upside

-   According to estimates from 9 analysts, Somnigroup International Inc. stock's average price target has fallen from $94.56 to $93, with forecasts ranging from $76 to $105 per share
-   Based on the Aug. 6 closing price, the updated target implies approximately 43% potential upside
-   Consensus rating remains at “Buy” across 12 covering analysts, with 10 Buys, 2 Holds and 0 Sells

Explore more price target data and ratings for Somnigroup International Inc. on the , and track all previous and future analyst recommendations for Somnigroup International Inc. in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [SGI.US](https://longbridge.com/en/quote/SGI.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Somnigroup publishes investor presentation outlining vertically integrated bedding strategy, omnichannel reach and capital allocation priorities](https://longbridge.com/en/news/295149721.md)
- [Somnigroup Q2 sales miss estimates, partly due to store closures](https://longbridge.com/en/news/295093757.md)
- [Pacer Advisors Inc. Lowers Holdings in CACI International, Inc. $CACI](https://longbridge.com/en/news/295208160.md)
- [Inter & Co reports Q2 results](https://longbridge.com/en/news/295057533.md)
- [Ascentage Pharma Appoints Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer | AAPG Stock News](https://longbridge.com/en/news/294616973.md)